{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "25849560", "DateCompleted": {"Year": "2016", "Month": "03", "Day": "27"}, "DateRevised": {"Year": "2020", "Month": "03", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "04", "Day": "07"}], "ELocationID": ["e0121298", "10.1371/journal.pone.0121298"], "Language": ["eng"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "4", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Evaluation of the medicinal herb Graptopetalum paraguayense as a treatment for liver cancer.", "Pagination": {"StartPage": "e0121298", "MedlinePgn": "e0121298"}, "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third most common cause of cancer-related death worldwide. Sorafenib is the only drug for patients with advanced-stage hepatocellular carcinoma (HCC) that has been shown to confer a survival benefit to patients with HCC; however, it has many side effects. Thus, alternate therapeutic strategies with improved safety and therapeutic efficacy for the management of HCC should be developed.", "We demonstrate that an extract of Graptopetalum paraguayense (GP) down-regulated the expression levels of several onco-proteins, including AURKA, AURKB, and FLJ10540, in HCC cells. To isolate the active components in the GP extracts, we prepared extracts fractions and assessed their effects on the expression of onco-proteins in HCC cells. The fraction designated HH-F3 was enriched in active ingredients, exhibited cytotoxic effects, and suppressed the expression of the onco-proteins in HCC cells. The structure of the main active compound in HH-F3 was found to be similar to that of the proanthocyanidin compounds derived from Rhodiola rosea. In addition, a distinct new compound rich in 3, 4, 5-trihydroxy benzylic moieties was identified in the HH-F3 preparations. Mechanistic studies indicated that HH-F3 induced apoptosis in HCC cells by promoting the loss of mitochondrial membrane potential and the production of reactive oxygen species. HH-F3 also enhanced PTEN expression and decreased AKT phosphorylation at Ser473 in a concentration-dependent manner in HCC cells. Moreover combination of GP or HH-F3 and sorafenib synergistically inhibits the proliferation of Huh7 cells. The treatment of a rat model with diethylnitrosamine (DEN)-induced liver cancer with extracts of GP and HH-F3 decreased hepatic collagen contents and inhibited tumor growth.", "These results indicate that GP extracts and HH-F3 can protect the liver by suppressing tumor growth; consequently, these compounds could be considered for the treatment of HCC."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan."}], "LastName": "Hsu", "ForeName": "Wei-Hsiang", "Initials": "WH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, National Taiwan University, Taipei, Taiwan."}], "LastName": "Chang", "ForeName": "Chia-Chuan", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery and Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan."}], "LastName": "Huang", "ForeName": "Kai-Wen", "Initials": "KW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan."}], "LastName": "Chen", "ForeName": "Yi-Chen", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan."}], "LastName": "Hsu", "ForeName": "Shih-Lan", "Initials": "SL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry and Graduate Institute of Biomedicine and Biomedical Technology, National Chi Nan University, Puli, Nantou, Taiwan."}], "LastName": "Wu", "ForeName": "Li-Chen", "Initials": "LC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan."}], "LastName": "Tsou", "ForeName": "Ann-Ping", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Science, Fu-Jen Catholic University, New Taipei City, Taiwan."}], "LastName": "Lai", "ForeName": "Jin-Mei", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan; Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan."}], "LastName": "Huang", "ForeName": "Chi-Ying F", "Initials": "CY"}], "PublicationTypeList": ["Evaluation Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Neoplasm Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Neoplasm Proteins"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Neoplasms, Experimental"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["chemistry"], "DescriptorName": "Saxifragaceae"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 53(3):1020\u20132. Epub 2011/03/05. 10.1002/hep.24199", "ArticleIdList": ["10.1002/hep.24199", "PMC3084991", "21374666"]}, {"Citation": "Suchankova G, Spicak J. [Sorafenib in the treatment of hepatocellular carcinoma]. Vnitr Lek. 57(5):485\u201390.", "ArticleIdList": ["21695929"]}, {"Citation": "Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer. World journal of gastroenterology: WJG. 2010;16(37):4627\u201333.", "ArticleIdList": ["PMC2951511", "20872961"]}, {"Citation": "Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2010;42 Suppl 3:S235\u201341. 10.1016/S1590-8658(10)60511-7", "ArticleIdList": ["10.1016/S1590-8658(10)60511-7", "20547309"]}, {"Citation": "van Malenstein H, van Pelt J, Verslype C. Molecular classification of hepatocellular carcinoma anno 2011. European journal of cancer. 2011;47(12):1789\u201397. 10.1016/j.ejca.2011.04.027", "ArticleIdList": ["10.1016/j.ejca.2011.04.027", "21612914"]}, {"Citation": "Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology. 2008;135(6):1972\u201383, 83 e1\u201311. Epub 2008/10/22. S0016-5085(08)01517-5. pii: 10.1053/j.gastro.2008.08.008", "ArticleIdList": ["10.1053/j.gastro.2008.08.008", "PMC2678688", "18929564"]}, {"Citation": "Galicia VA, He L, Dang H, Kanel G, Vendryes C, French BA, et al. Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. Gastroenterology. 2010;139(6):2170\u201382. 10.1053/j.gastro.2010.09.002", "ArticleIdList": ["10.1053/j.gastro.2010.09.002", "PMC2997180", "20837017"]}, {"Citation": "Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology. 2011;140(3):1071\u201383. 10.1053/j.gastro.2010.12.006", "ArticleIdList": ["10.1053/j.gastro.2010.12.006", "PMC3057329", "21147110"]}, {"Citation": "Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7(10):3129\u201340. 7/10/3129. pii: 10.1158/1535-7163.MCT-08-0013", "ArticleIdList": ["10.1158/1535-7163.MCT-08-0013", "18852116"]}, {"Citation": "Vullierme MP, Paradis V, Chirica M, Castaing D, Belghiti J, Soubrane O, et al. Hepatocellular carcinoma--what's new? J Visc Surg. 147(1):e1\u201312. S1878-7886(10)00006-8. pii: 10.1016/j.jviscsurg.2010.02.003", "ArticleIdList": ["10.1016/j.jviscsurg.2010.02.003", "20595072"]}, {"Citation": "Muntane J. Targeting cell death and survival receptors in hepatocellular carcinoma. Anticancer Agents Med Chem. 11(6):576\u201384. BSP/ACAMC/E-Pub/ 00176.", "ArticleIdList": ["21554206"]}, {"Citation": "Croswell JM, Kramer BS. Clinical trial design and evidence-based outcomes in the study of liver diseases. J Hepatol. 2009;50(4):817\u201326. S0168-8278(09)00060-9. pii: 10.1016/j.jhep.2009.01.005", "ArticleIdList": ["10.1016/j.jhep.2009.01.005", "19231015"]}, {"Citation": "Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378\u201390. 359/4/378. pii: 10.1056/NEJMoa0708857", "ArticleIdList": ["10.1056/NEJMoa0708857", "18650514"]}, {"Citation": "Chung YC, Chen SJ, Hsu CK, Chang CT, Chou ST. Studies on the antioxidative activity of Graptopetalum paraguayense E. Walther. Food Chemistry. 2005;91(3): 419\u201324."}, {"Citation": "Huang KF, Chen YW, Chang CT, Chou ST. Studies on the inhibitory effect of Graptopetalum paraguayense E. Walther extracts on mushroom tyrosinase. Food Chemistry. 2005;89(4): 583\u20137.", "ArticleIdList": ["0"]}, {"Citation": "Chen SJ, Chang CT, Chung YC, Chou ST. Studies on the inhibitory effect of Graptopetalum paraguayense E. Walther extracts on the angiotensin converting enzyme. Food Chemistry. 2007;100(3): 1032\u20136."}, {"Citation": "Chen SJ, Chung JG, Chung YC, Chou ST. In vitro antioxidant and antiproliferative activity of the stem extracts from Graptopetalum paraguayense. Am J Chin Med. 2008;36(2):369\u201383. S0192415X08005837.", "ArticleIdList": ["18457367"]}, {"Citation": "Duh PD, Lin SL, Wu SC. Hepatoprotection of Graptopetalum paraguayense E. Walther on CCl(4)-induced liver damage and inflammation. J Ethnopharmacol. 134(2):379\u201385. S0378-8741(10)00905-0. pii: 10.1016/j.jep.2010.12.029", "ArticleIdList": ["10.1016/j.jep.2010.12.029", "21195152"]}, {"Citation": "Su LJ, Yang CH, Huang SF, Yuo YL, Hsieh HC, Tseng TL, et al. Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models. Evidence-based complementary and alternative medicine: eCAM. 2012;2012:256561 10.1155/2012/256561", "ArticleIdList": ["10.1155/2012/256561", "PMC3395323", "22811744"]}, {"Citation": "Su LJ, Chang CC, Yang CH, Hsieh SJ, Wu YC, Lai JM, et al. Graptopetalum paraguayense ameliorates chemical-induced rat hepatic fibrosis in vivo and inactivates stellate cells and Kupffer cells in vitro. PLoS One. 2013;8(1): e53988 10.1371/journal.pone.0053988", "ArticleIdList": ["10.1371/journal.pone.0053988", "PMC3545924", "23335984"]}, {"Citation": "Juan YC, Chang CC, Tsai WJ, Lin YL, Hsu YS, Liu HK. Pharmacological evaluation of insulin mimetic novel suppressors of PEPCK gene transcription from Paeoniae Rubra Radix. J Ethnopharmacol. 2011;137(1): 592\u2013600. 10.1016/j.jep.2011.06.007", "ArticleIdList": ["10.1016/j.jep.2011.06.007", "21704145"]}, {"Citation": "Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ, Tsou AP, et al. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene. 2007;26(29): 4272\u201383. 1210207. pii: 10.1038/sj.onc.1210207", "ArticleIdList": ["10.1038/sj.onc.1210207", "17237822"]}, {"Citation": "Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res. 2004;10(6):2065\u201371.", "ArticleIdList": ["15041727"]}, {"Citation": "Lin ZZ, Jeng YM, Hu FC, Pan HW, Tsao HW, Lai PL, et al. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. BMC Cancer. 10:461 Epub 2010/08/31. 1471-2407-10-461. pii: 10.1186/1471-2407-10-461", "ArticleIdList": ["10.1186/1471-2407-10-461", "PMC2940801", "20799978"]}, {"Citation": "Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res. 2007;5(1):1\u201310. 5/1/1 [pii] 10.1158/1541-7786.MCR-06-0208", "ArticleIdList": ["10.1158/1541-7786.MCR-06-0208", "17259342"]}, {"Citation": "Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003;22(4):451\u201364.", "ArticleIdList": ["12884918"]}, {"Citation": "Zhao WM, Seki A, Fang G. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Mol Biol Cell. 2006;17(9):3881\u201396. E06-01-0015 [pii] 10.1091/mbc.E06-01-0015", "ArticleIdList": ["10.1091/mbc.E06-01-0015", "PMC1593165", "16790497"]}, {"Citation": "Skulachev VP. Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis: an international journal on programmed cell death. 2006;11(4): 473\u201385. 10.1007/s10495-006-5881-9", "ArticleIdList": ["10.1007/s10495-006-5881-9", "16532373"]}, {"Citation": "Jacotot E, Deniaud A, Borgne-Sanchez A, Touat Z, Briand JP, Le Bras M, et al. Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis. Biochimica et biophysica acta. 2006;1757(9\u201310): 1312\u201323. 10.1016/j.bbabio.2006.07.002", "ArticleIdList": ["10.1016/j.bbabio.2006.07.002", "16928356"]}, {"Citation": "Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer research. 2010;70(2):440\u20136. 10.1158/0008-5472.CAN-09-1947", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1947", "20068163"]}, {"Citation": "Dulundu E, Ozel Y, Topaloglu U, Toklu H, Ercan F, Gedik N, et al. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction. J Gastroenterol Hepatol. 2007;22(6):885\u201392. JGH4875 [pii] 10.1111/j.1440-1746.2007.04875.x", "ArticleIdList": ["10.1111/j.1440-1746.2007.04875.x", "17565645"]}, {"Citation": "Neuwirt H, Arias MC, Puhr M, Hobisch A, Culig Z. Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells. Prostate. 2008;68(15):1647\u201354. 10.1002/pros.20829", "ArticleIdList": ["10.1002/pros.20829", "18663730"]}, {"Citation": "Shin MO, Yoon S, Moon JO. The proanthocyanidins inhibit dimethylnitrosamine-induced liver damage in rats. Arch Pharm Res. 33(1):167\u201373. 10.1007/s12272-010-2239-1", "ArticleIdList": ["10.1007/s12272-010-2239-1", "20191358"]}, {"Citation": "Wu JJ, Sun WY, Hu SS, Zhang S, Wei W. A standardized extract from Paeonia lactiflora and Astragalus membranaceus induces apoptosis and inhibits the proliferation, migration and invasion of human hepatoma cell lines. International journal of oncology. 2013;43(5): 1643\u201351. 10.3892/ijo.2013.2085", "ArticleIdList": ["10.3892/ijo.2013.2085", "24002667"]}, {"Citation": "Ha KT, Kim JK, Kang SK, Kim DW, Lee YC, Kim HM, et al. Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma. Pharmacological research: the official journal of the Italian Pharmacological Society. 2004;50(3): 279\u201385. 10.1016/j.phrs.2004.02.006", "ArticleIdList": ["10.1016/j.phrs.2004.02.006", "15225671"]}, {"Citation": "Tsuchiya M, Kono H, Matsuda M, Fujii H, Rusyn I. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. International journal of cancer Journal international du cancer. 2008;123(11): 2503\u201311. 10.1002/ijc.23828", "ArticleIdList": ["10.1002/ijc.23828", "PMC2571981", "18785209"]}, {"Citation": "Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res. 2008;52(5): 507\u201326. 10.1002/mnfr.200700326", "ArticleIdList": ["10.1002/mnfr.200700326", "18435439"]}, {"Citation": "Ray SD, Parikh H, Bagchi D. Proanthocyanidin exposure to B6C3F1 mice significantly attenuates dimethylnitrosamine-induced liver tumor induction and mortality by differentially modulating programmed and unprogrammed cell deaths. Mutat Res. 2005;579(1\u20132):81\u2013106. S0027-5107(05)00253-8 [pii] 10.1016/j.mrfmmm.2005.02.017", "ArticleIdList": ["10.1016/j.mrfmmm.2005.02.017", "16197968"]}, {"Citation": "Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3(10):768\u201380. 10.1038/nrc1189", "ArticleIdList": ["10.1038/nrc1189", "14570043"]}, {"Citation": "Kwon YW, Kim IJ, Wu D, Lu J, Stock WA Jr, Liu Y, et al. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development. Mol Cancer Res. 2012;10(6): 834\u201344. 10.1158/1541-7786.MCR-12-0025", "ArticleIdList": ["10.1158/1541-7786.MCR-12-0025", "PMC3388112", "22513362"]}, {"Citation": "Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer research. 2005;65(7): 2899\u2013905. 10.1158/0008-5472.CAN-04-3981", "ArticleIdList": ["10.1158/0008-5472.CAN-04-3981", "15805292"]}, {"Citation": "He W, Zhang MG, Wang XJ, Zhong S, Shao Y, Zhu Y, et al. AURKA suppression induces DU145 apoptosis and sensitizes DU145 to docetaxel treatment. American journal of translational research. 2013;5(3): 359\u201367.", "ArticleIdList": ["PMC3633978", "23634246"]}, {"Citation": "Long M, Yin G, Liu L, Lin F, Wang X, Ren J, et al. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells. Cancer gene therapy. 2012;19(4): 271\u201381. 10.1038/cgt.2011.89", "ArticleIdList": ["10.1038/cgt.2011.89", "22281755"]}, {"Citation": "Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J. 2008;415(3):333\u201344. BJ20081056 [pii] 10.1042/BJ20081056", "ArticleIdList": ["10.1042/BJ20081056", "18842113"]}, {"Citation": "Shi DY, Liu HL, Stern JS, Yu PZ, Liu SL. Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway. FEBS Lett. 2008;582(12): 1667\u201371. S0014-5793(08)00339-6 [pii] 10.1016/j.febslet.2008.04.021", "ArticleIdList": ["10.1016/j.febslet.2008.04.021", "18435927"]}, {"Citation": "Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 2005;11(7):725\u201330. nm1263 [pii] 10.1038/nm1263", "ArticleIdList": ["10.1038/nm1263", "16015365"]}, {"Citation": "Paquet P, Pierard GE. Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review). Int J Mol Med. 2007;19(1): 3\u201310.", "ArticleIdList": ["17143541"]}, {"Citation": "Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1): 1\u201313. BJ20081386 [pii] 10.1042/BJ20081386", "ArticleIdList": ["10.1042/BJ20081386", "PMC2605959", "19061483"]}, {"Citation": "Xu L, Han C, Lim K, Wu T. Cross-talk between peroxisome proliferator-activated receptor delta and cytosolic phospholipase A(2)alpha/cyclooxygenase-2/prostaglandin E(2) signaling pathways in human hepatocellular carcinoma cells. Cancer research. 2006;66(24): 11859\u201368. 10.1158/0008-5472.CAN-06-1445", "ArticleIdList": ["10.1158/0008-5472.CAN-06-1445", "17178883"]}, {"Citation": "Wang Z, Wang M, Carr BI. Involvement of receptor tyrosine phosphatase DEP-1 mediated PI3K-cofilin signaling pathway in sorafenib-induced cytoskeletal rearrangement in hepatoma cells. Journal of cellular physiology. 2010;224(2): 559\u201365. 10.1002/jcp.22160", "ArticleIdList": ["10.1002/jcp.22160", "20432459"]}, {"Citation": "Huang KW, Huang YC, Tai KF, Chen BH, Lee PH, Hwang LH. Dual therapeutic effects of interferon-alpha gene therapy in a rat hepatocellular carcinoma model with liver cirrhosis. Molecular therapy: the journal of the American Society of Gene Therapy. 2008;16(10): 1681\u20137. 10.1038/mt.2008.160", "ArticleIdList": ["10.1038/mt.2008.160", "18665156"]}, {"Citation": "Heindryckx F, Colle I, Van Vlierberghe H. Experimental mouse models for hepatocellular carcinoma research. International journal of experimental pathology. 2009;90(4): 367\u201386. 10.1111/j.1365-2613.2009.00656.x", "ArticleIdList": ["10.1111/j.1365-2613.2009.00656.x", "PMC2741148", "19659896"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "8", "Day": "19"}, {"Year": "2015", "Month": "1", "Day": "29"}, {"Year": "2015", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["25849560", "PMC4388720", "10.1371/journal.pone.0121298", "PONE-D-14-36876"]}}], "PubmedBookArticle": []}